Scholtz & Company’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $584K | Buy |
6,686
+90
| +1% | +$7.86K | 0.26% | 40 |
|
|
2025
Q1 | $450K | Buy |
+6,596
| New | +$450K | 0.22% | 40 |
|
|
2024
Q4 | – | Sell |
-25,527
| Closed | -$1.71M | – | 50 |
|
|
2024
Q3 | $1.71M | Sell |
25,527
-1,330
| -5% | -$89.2K | 0.81% | 33 |
|
|
2024
Q2 | $3.05M | Buy |
26,857
+1,059
| +4% | +$120K | 1.3% | 27 |
|
|
2024
Q1 | $3.58M | Buy |
25,798
+3,259
| +14% | +$452K | 1.58% | 25 |
|
|
2023
Q4 | $2.8M | Buy |
+22,539
| New | +$2.8M | 1.38% | 25 |
|